Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory Prostate Cancer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03344211
What this trial is testing

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Southern California 30
Early research (Phase 1)Looking for participantsNCT05743621
What this trial is testing

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Weill Medical College of Cornell University 30
Early research (Phase 1)Active Not RecruitingNCT06895811
What this trial is testing

Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Shanghai Changzheng Hospital 3
Early research (Phase 1)Study completedNCT00302471
What this trial is testing

MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 29
Large-scale testing (Phase 3)Study completedNCT00110214
What this trial is testing

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 1,050
Early research (Phase 1)Active Not RecruitingNCT04506567
What this trial is testing

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 60
Testing effectiveness (Phase 2)Study completedNCT03392428
What this trial is testing

A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Cancer of the ProstateMetastatic Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 201
Early research (Phase 1)Study completedNCT03123978
What this trial is testing

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
University of California, Davis 6
Early research (Phase 1)Study completedNCT01385228
What this trial is testing

Pazopanib, Docetaxel, Prednisone Prostate

Who this might be right for
Prostate Cancer
Daniel George, MD 36
Testing effectiveness (Phase 2)Looking for participantsNCT06216249
What this trial is testing

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Who this might be right for
Prostate CarcinomaStage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Jonsson Comprehensive Cancer Center 90
Early research (Phase 1)WithdrawnNCT05807126
What this trial is testing

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
National Cancer Institute (NCI)
Very early researchNot Yet RecruitingNCT06546527
What this trial is testing

Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

Who this might be right for
Prostate Cancer
Peking University First Hospital 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05204927
What this trial is testing

177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastasis From Malignant Tumor of Prostate
Curium US LLC 439
Testing effectiveness (Phase 2)Study completedNCT00901342
What this trial is testing

Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Dendreon 104
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Study completedNCT00004149
What this trial is testing

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 37
Testing effectiveness (Phase 2)UnknownNCT05156450
What this trial is testing

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-ResistantDrug Therapy, Combination
West China Hospital 30
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)Looking for participantsNCT06236139
What this trial is testing

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00038168
What this trial is testing

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 14
Next Page